Local Anesthetic Agent

Embed Size (px)

Citation preview

  • 7/30/2019 Local Anesthetic Agent

    1/21

    Local anaestheticagents

    5/2/2013 1

  • 7/30/2019 Local Anesthetic Agent

    2/21

    The Pharmacology of Local Anaesthetic Agents (LA)

    Local anaesthetic agents can be defined as drugs,which are used clinically to produce reversible loss of

    sensation in a circumscribed area of the body.

    Classification :The molecule of the clinically

    useful LA agents consists of

    1. A tertiary amine attached to an

    2. Aromatic ring by an

    3. Intermediate chain.5/2/2013 2

  • 7/30/2019 Local Anesthetic Agent

    3/21

  • 7/30/2019 Local Anesthetic Agent

    4/21

    There are important practical differences between these

    2 groups of LA agents

    Esters are relatively unstable in solution Amidesare relatively stable in solution

    Esters are rapidly hydrolysed in the body by plasmacholinesterase (and other esterases)

    Amides are slowly metabolised by hepatic amidases and

    Esters: One of the main breakdown products is para-aminobenzoate (PABA) which is associated with allergic phenomenaand hypersensitivity reactions

    Amides: hypersensitivity reactions to amide local anaestheticsare extremely rare

    In current clinical practice esters have largely been superseded bythe amides.

    5/2/2013 4

  • 7/30/2019 Local Anesthetic Agent

    5/21

    Mode of action-Membrane structure

    5/2/2013 5

  • 7/30/2019 Local Anesthetic Agent

    6/21

    Mode of action

    After injection, the tertiary amine base is liberated

    by the relatively alkaline pH of tissue fluids: These effects are due to blockade of sodium

    channels, thereby impairing sodium ion flux,across the membrane.

    B.HCl + HCO3 B + H2CO3 + Cl- In clinical practice, local anaesthesia may beinfluenced by the local availability of free base(B), as only the unionised portion can diffusethrough the neuronal membrane. Thus, local

    anaesthetics are relatively inactive when injectedinto tissues with an acid pH (e.g. pyogenicabscess), which is presumably due to reducedrelease of free base.

    5/2/2013 6

  • 7/30/2019 Local Anesthetic Agent

    7/21

    Preparations of LA LA agents are usually acid (pH range 4.0-5.5)

    and contain1. reducing agent (e.g. sodium metabisulphite)

    to enhance the stability of added

    vasoconstrictors2. preservative and a fungicide

    5/2/2013 7

  • 7/30/2019 Local Anesthetic Agent

    8/21

    What does 1% Lidocain mean?The dilute preparations are presented as percentage (%)solutions

    of LA.

    A solution expressed as 1% contains 1g substance in each

    100mls1 g in 100 ml = 1000mg in 100 ml 10 mg in 1 mlThe number of mg/ml can easily be calculated by

    multiplying the percentage strength by10. Therefore a 0.25% solution of lidocaine contains2.5mg/ml of solution (10 * 0.25=2.5 mg /ml)

    5/2/2013 8

  • 7/30/2019 Local Anesthetic Agent

    9/21

    vasoconstrictors

    Most LA produce some degree ofvasodilation, andthey may be rapidly absorbed after local injection.

    vasoconstrictors decrease the systemic toxicity andincrease the safety margin of local anaesthetics by

    reducing their rate of absorption vasoconstrictors are frequently added to LA to

    enhance their potency and prolong their duration ofaction

    Adrenaline is the most commonly usedvasoconstrictorin concentrations ranging from 1 in80,000 to 1 in 300,000

    5/2/2013 9

  • 7/30/2019 Local Anesthetic Agent

    10/21

    How can I prepare Adrenaline 1:200000?

    Adrenaline dilution 1:200000 means

    1 g in 200000 ml = 1000 mg in 200000 ml

    1 mg in 200 ml = 0.1 mg in 20 ml

    1:80000..= 0.1 mg in 8 ml5/2/2013 10

    Plain mg/Kg With Adrenalinemg/Kg

    Lidocaine 3 7

    Prilocaine 6 9

    Bupivacaine 2 2

  • 7/30/2019 Local Anesthetic Agent

    11/21

    contraindication for Adrenaline containing

    local anaesthetic agents:

    agents

    Absolute contraindication (should never be used)for: 1.infiltration around end-arteries i.e. ring

    block of fingers, penis or other areas with a

    terminal vascular supply as the intense

    vasoconstriction may lead to severe ischaemia and

    necrosis.

    2. Intravenous regional anaesthesia (IVRA)

    Relative contraindication:

    1.Patient with severe hypertension

    2.General anaesthesia with halothane5/2/2013 11

  • 7/30/2019 Local Anesthetic Agent

    12/21

    Clinical Uses of Local Anaesthetics

    5/2/2013 12

    1. Topical Anaesthesia

    2. Infiltration Anaesthesia

    3. Intravenous regional anaesthesia

    (IVRA)

    4. Peripheral Nerve Blockade

    5. Extradural Anaesthesia

    6. Spinal Anaesthesia

    7. Tumescent Anesthesia

  • 7/30/2019 Local Anesthetic Agent

    13/21

    : op ca naes es a

    LA may be applied to the skin, the eye, the ear, the nose

    and the mouth as well as othermucous membranes.most

    useful and effective: Lidocaine (i.e.gel 2%) and

    prilocaine(i.e.EMLA)

    2: Infiltration Anaesthesiaprovide anaesthesia for minor surgical procedures.

    commonly used Amide LA are (Lidocaineprilocaine,mepivacaine and Bupivacaine).,The site of action is at unmyelinated nerve endings and

    onset is almost immediate

    5/2/2013 13

  • 7/30/2019 Local Anesthetic Agent

    14/21

    3: Intravenous regional anaesthesia (IVRA)

    IVRA (BIER s Block) analgesia for minor surgical procedures. The

    local anaesthetic agent is injected into a vein of a limb that

    has been previously exsanguinated and occluded by a

    tourniquet.

    The site of action is probably the unmyelinated nerve

    fibres,Prilocaine and Ldocaine are commonly used.Bupivacaine and etidocaineshould never be used for

    IVRA! They are significantly protein bound and once thetourniquet is released there is a risk of cardiotoxicity. Several

    deaths have been reported during IVRA with bupivacaine.

    5/2/2013 14

  • 7/30/2019 Local Anesthetic Agent

    15/21

    4: Peripheral Nerve Blockade :

    Regional anestheticprocedures that inhibit conduction in fibers ofthe peripheral nervous system. It can be devided into:

    Minor nerve blocks involve the blocking of single nerveentities such as the inferior alveolar nerve, mental nerve, ulnaror radial nerve.

    Major nerve blocks involve the blocking of deeper nerves or trunkswith a wide dermatomal distribution (e.g. brachial plexusblockade).

    The commonly used LA agents are: Lidocaine, prilocaine,mepivacaine, and bupivacaine.

    5/2/2013 15

  • 7/30/2019 Local Anesthetic Agent

    16/21

    epidural space between the dura mater and the

    Lig.Flavum. The epidural space contains adipose tissue,

    lymphatics and blood vessels. LA produces analgesia by

    blocking conduction at the intradural spinal nerve roots.

    usually used 0.5% Bupivacaine (mainly) or lidocaine (2.0%)6.: Spinal Anaesthesiainjction directly into the cerebrospinal

    fluid (subarachnoid space) produces spinal anaesthesia.commonly used : Bupivacaine 0.5% (mainly hyperbaric), lidocaine (5%)

    7.: Tumescent Anesthesia A technique most commonly employedby plastic surgeons during liposuction procedures

    5/2/2013 16

  • 7/30/2019 Local Anesthetic Agent

    17/21

    Toxicity from Local Anaesthetic Drugs

    when excessive blood levels occur. usually due to:

    1. Accidental rapid intravenous injection.

    2. Rapid absorption, such as from a very vascular site ie

    mucous membranes. Intercostal nerve blocks will give a

    higher blood level than subcutaneous infiltration,whereas plexus blocks are associated with the slowest

    rates of absorption and therefore give the lowest blood

    levels.

    3. Absolute overdose if the dose used is excessive.

    5/2/2013 17

  • 7/30/2019 Local Anesthetic Agent

    18/21

    Signs and Symptoms of LA Toxicity

    It involves the CNS and CVS. In general (CNS) is more sensitive

    to LA than the CVS. Therefore CNS manifestations tend tooccur earlier. Brain excitatory effects occur before the

    depressant effects.

    CNS signs & symptomsEarly or mild toxicity: light-headedness, dizziness, tinnitus,

    circumoral numbness, confusion and drowsiness. Patients

    often will not volunteer information about these symptoms

    unless asked.

    Severe toxicity: tonic-clonic convulsion leading to progressive

    loss of consciousness, coma, respiratory depression, and

    respiratory arrest.

    5/2/2013 18

  • 7/30/2019 Local Anesthetic Agent

    19/21

    CVS signs & symptoms

    Early or mild toxicity: if LAwith Adrenaline tachycardia

    with Hypertension

    If no Adrenaline : bradycardia with hypotension

    Severe toxicity: Usually about 4 - 7 times the convulsant

    dose needs to be injected before CV collapse occurs.

    Collapse is due to the depressant effect of the LA acting

    directly on the myocardium (e.g. Bupivacaine)

    Severe and intractable arrhythmias can occur with

    accidental iv injection.

    5/2/2013 19

  • 7/30/2019 Local Anesthetic Agent

    20/21

    Essential Precautions and Treatment

    Precautions: Secure intravenous access before injectionof any dose that . Always have adequate resuscitation

    equipment and drugs available before starting to inject.

    Treatment: stop the injection and assess the patient.Call for help while treating the patient

    Ensure an adequate airway, give O2 in over facemask . Ventilate

    the patient if there is inadequate spontaneous respiration

    Intubation : if the patient is unconscious and unable to maintain

    an airway.

    5/2/2013 20

  • 7/30/2019 Local Anesthetic Agent

    21/21

    Treatment of circulatory failure

    with I.V fluids and vasopressors:Ephedrin : If

    not available or not effective in correctingthe hypotension .Adrenaline

    Treat arrhythmias. Start chest

    compressions if cardiac arrest occurs. Treat Convulsions with anticonvulsantdrugs

    (Diazepam 0.2-0.4mg/kg , Thiopentone 1-4 mg/kg)

    5/2/2013 21